lol646 casino online games tips and tricks

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.WASHINGTON (AP) — President-elect Donald Trump on Thursday named Pam Bondi, the former attorney general of Florida, to be U.S. attorney general just hours after his other choice, Matt Gaetz , withdrew his name from consideration. Bondi is a longtime Trump ally and was one of his lawyers during his first impeachment trial, when he was accused — but not convicted — of abusing his power as he tried to condition U.S. military assistance to Ukraine on that country investigating then-former Vice President Joe Biden. Bondi was among a group of Republicans who showed up to support Trump at his hush money criminal trial in New York that ended in May with a conviction on 34 felony counts. She's been a chair at the America First Policy Institute, a think tank set up by former Trump administration staffers. “For too long, the partisan Department of Justice has been weaponized against me and other Republicans - Not anymore,” Trump said in a social media post. “Pam will refocus the DOJ to its intended purpose of fighting Crime, and Making America Safe Again.” Trump’s son Donald Trump Jr. told Fox Business on Sunday that the transition team had backups in mind for his controversial nominees should they fail to get confirmed. The swift selection of Bondi came about six hours after Gaetz withdrew. Gaetz stepped aside amid continued fallout over a federal sex trafficking investigation that cast doubt on his ability to be confirmed as the nation's chief federal law enforcement officer. That announcement capped a turbulent eight-day period in which Trump sought to capitalize on his decisive election win to force Senate Republicans to accept provocative selections like Gaetz, who had been investigated by the Justice Department before being tapped last week to lead it. The decision could heighten scrutiny on other controversial Trump nominees, including Pentagon pick Pete Hegseth , who faces sexual assault allegations that he denies. “While the momentum was strong, it is clear that my confirmation was unfairly becoming a distraction to the critical work of the Trump/Vance Transition,” Gaetz, a Florida Republican who one day earlier met with senators in an effort to win their support, said in a statement. “There is no time to waste on a needlessly protracted Washington scuffle, thus I’ll be withdrawing my name from consideration to serve as Attorney General. Trump’s DOJ must be in place and ready on Day 1," he added. Hours later, Gaetz posted on social media that he looks “forward to continuing the fight to save our country,” adding, “Just maybe from a different post.” Trump, in a social media post, said: “I greatly appreciate the recent efforts of Matt Gaetz in seeking approval to be Attorney General. He was doing very well but, at the same time, did not want to be a distraction for the Administration, for which he has much respect. Matt has a wonderful future, and I look forward to watching all of the great things he will do!” Last week, Trump named personal lawyers Todd Blanche, Emil Bove and D. John Sauer to senior roles in the department. Another possible attorney general contender, Matt Whitaker, was announced Wednesday as the U.S. ambassador to NATO. Bondi, too, is a longtime loyalist. She has been a vocal critic of the criminal cases against Trump as well as Jack Smith, the special counsel who charged Trump in two federal cases. In one radio appearance, she blasted Smith and other prosecutors who have charged Trump as “horrible” people she said were trying to make names for themselves by “going after Donald Trump and weaponizing our legal system.” If confirmed by the Republican-led Senate, Bondi would instantly become one of the most closely watched members of Trump’s Cabinet given the Republican’s threat to pursue retribution against perceived adversaries and concern among Democrats that he will look to bend the Justice Department to his will. A recent Supreme Court opinion not only conferred broad immunity on former presidents but also affirmed a president’s exclusive authority over the Justice Department’s investigative functions. Bondi would inherit a Justice Department expected to pivot sharply on civil rights, corporate enforcement and the prosecutions of hundreds of Trump supporters charged in the Jan. 6, 2021, riot at the U.S. Capitol — defendants whom Trump has pledged to pardon . It’s unlikely that Bondi would be confirmed in time to overlap with Smith, who brought two federal indictments against Trump that are both expected to wind down before the incoming president takes office. Special counsels are expected to produce reports on their work that historically are made public, but it remains unclear when such a document might be released. In 2013, while serving as Florida attorney general, Bondi publicly apologized for asking that the execution of a man convicted of murder be delayed because it conflicted with a campaign fundraiser. Bondi said she was wrong and sorry for requesting then-Gov. Rick Scott push back the execution of Marshall Lee Gore by three weeks. Before she ran for state attorney general in 2010, Bondi worked for the Hillsborough County state attorney. Associated Press writers Zeke Miller, Michelle L. Price, Lisa Mascaro, Mary Clare Jalonick and Adriana Gomez Licon contributed to this report.It was fall 1970, and having finished much of the work on Led Zeppelin’s now-iconic Led , Jimmy Page turned his attention to a slew of upcoming tour dates beginning March 5, 1971. Though the album would not be released until November ’71, the band planned to debut future classics like “Black Dog,” “Rock and Roll,” “Going to California,” and the evocative piece that was to become their signature song: “Stairway to Heaven.” There was just one catch. “I was so involved in creating the guitar parts for ‘Stairway to Heaven,’ on the acoustic guitar and two [ ] electric 12-string” Page recalls in , “that I hadn’t been thinking about how I was going to perform it all live. That’s where the Double-Neck came in.” Gibson had been making a model designated as the EDS-1275 SG Double-Neck since 1963 (Elvis Presley even totes one in his 1966 film ), and while the guitar fell off Gibson’s price list in 1968 (only to be re-continued in 1974), Page was able to custom-order one, which he received in early 1971, just in time for the tour. It’s this very same 1969 EDS-1275 that provided the model for last year’s limited-edition run of the Gibson Jimmy Page 1969 EDS-1275 Double-Neck Collector’s Edition. Custom-aged to the original’s exact wear detail by Gibson’s in-house Murphy Lab, only 50 Collector’s Editions were made, each hand-signed and actually played by Page himself, all for a tidy $49,999. While those have sold out, Gibson is soon to announce its plan to begin producing the Gibson Custom Jimmy Page EDS-1275 VOS, with some differences in specs, starting this December, at the more manageable price-point of $9,999. It’s worth noting that the Collector’s Edition, as well as the forthcoming Jimmy Page VOS model, are not mere approximations of Page’s instrument. Instead, using advanced 3D scanning technology, in tandem with CAD diagrams and CNC machining equipment, each and every component of the guitar, including the mahogany body, the ABR-1 bridges, and even the headstock logos, are scanned and then tooled to duplicate the parts on Page’s EDS to the minutest detail. And that’s not even to mention the minutiae behind replicating Page’s original T-Top pickups, where readings for ohm resistance, gauss (the magnetic charge in a pickup), number of winds, and more were all duly registered. “All of the parts will match exactly what was used in 1968/’69,” explains Mat Koehler, Gibson’s vice president of product, “down to the precise material of the chrome-plated bridges, the exact saddle contour and shape, the butyrate [ ] knobs and even how the reflectors are mounted within those knobs. We now have what’s known as a five-axis CNC machining tool, which allows us to do incredibly intricate carvings, and this means a lot more attention to detail.” All the latest guitar news, interviews, lessons, reviews, deals and more, direct to your inbox! Calling Page’s original EDS “the lightest solid-body double-neck I’ve ever played,” Koehler says his other first observation of the guitar when he met with Page at his home near London last year to conduct the scans was its overall condition. “Especially for a guitar that saw as much touring as Jimmy’s did, his EDS is in excellent shape,” Koehler says. “It was obvious that he’s very proud of it, and that he’s been a really great caretaker.” One Piece Mahogany Murphy Lab Aged Nitrocellulose Lacquer 628.65 mm / 24.75 in al Indian Rosewood 304.8 mm / 12 in Mahogany 42.8625 mm / 1.687 in Kluson Double Line, Double Ring with Keystone Button Jimmy Page EDS-1275 Custombuckers, Double Black Bobbins, Alnico 5 Jimmy Page EDS-1275 Custombuckers, Double Black Bobbins, Alnico 5 2 Volume, 2 Tone; Hand-wired with CTS Potentiometers and Period-correct Ceramic Disc Capacitors 3-way Switchcraft plus 3-way Switchcraft Neck Select Switch A former editor at and , and an ex-member of Humble Pie, Mr. Bungle and French band AIR, author James Volpe Rotondi plays guitar for the acclaimed Led Zeppelin tribute, ZOSO, which has called “head and shoulders above all other Led Zeppelin tribute bands.” Find JVR on Instagram at @james.volpe.rotondi, on the web at JVRonGTR.com, and look for upcoming tour dates at zosoontour.comlol646 casino online games tips and tricks 。

Notable quotes by Jimmy CarterCCSC Technology International Holdings Limited Reports Financial Results for the First Six Months of Fiscal Year 2025 Ended September 30, 2024

WASHINGTON (AP) — President-elect Donald Trump’s transition team on Tuesday signed an agreement to allow the Justice Department to conduct background checks on his nominees and appointees after a weeks-long delay. The step lets Trump transition aides and future administration staffers obtain security clearances before Inauguration Day to access classified information about ongoing government programs, an essential step for a smooth transiton of power. It also allows those nominees who are up for Senate confirmation to face the background checks lawmakers want before voting on them. Teams of investigators have been standing by to process clearances for Trump aides and advisers. “This agreement with the Department of Justice will ensure President Trump and his team are ready on Day 1 to begin enacting the America First Agenda that an overwhelming majority of our nation supported on Election Day,” said Susie Wiles, Trump’s designate to be White House chief of staff. Related Articles The announcement comes a week after the Trump transition team with the Biden White House to allow transition staff to coordinate with the existing federal workforce before taking office on Jan. 20. The White House agreement was supposed to have been signed by Oct. 1, according to the Presidential Transition Act, and the Biden White House had issued both public and private appeals for Trump’s team to sign on. Security clearances are required to access classified information, including on ongoing operations and threats to the nation, and the Biden White House and outside experts have emphasized to Trump’s team the importance of having cleared personnel before Inauguration Day so they could be fully briefed and ready to run the government. Republican Senators have also insisted on FBI background checks for Trump’s nominees before they face confirmation votes, as has been standard practice for decades. Lawmakers have been particularly interested in seeing the findings of reviews into Trump’s designated nominee for defense secretary, former Fox News host Pete Hegseth, and for Rep. Tulsi Gabbard to be director of national intelligence. “That’s why it’s so important that we have an FBI background check, a committee review of extensive questions and questionnaires, and a public hearing,” said. Sen. Susan Collins, R-Maine on Monday. John Thune, the incoming Senate Republican leader, said the Trump team “understands there’s going to have to be a thorough vetting of all these nominees.”

Democrats stick with Schumer as leader. Their strategy for countering Trump is far less certainTimberwolves' game against Spurs will start late because of issue with court

Barstool Sports founder Dave Portnoy was quick to celebrate Michigan’s massive recruiting victory on Thursday, but that does not mean he had a direct hand in making it happen. Bryce Underwood, who is the No. 1 overall recruit for the class of 2025, has announced his commitment to the Wolverines. Underwood, who is from Belleville, Mich., had previously been committed to LSU, but the quarterback changed his commitment. Portnoy, who is a Michigan alumnist and fan of the Wolverines, had previously indicated he was prepared to spend millions of dollars to bring his school a top quarterback. Did he do that to help Michigan land Underwood? It doesn’t sound like it. Though Portnoy shared a video on social media boasting about Underwood’s commitment , he later said his role in bringing the quarterback to Ann Arbor was “tiny.” “Im getting tons of credit online for flipping Bryce. While I love credit reality is I played a tiny roll (sic). Rest assured there are Michigan Men + Women out there making things happen behind the scenes. I’ve never been more confident that Mich is poised to dominate in this new world,” Portnoy wrote on X. Im getting tons of credit online for flipping Bryce. While I love credit reality is I played a tiny roll. Rest assured there are Michigan Men + Women out there making things happen behind the scenes. I've never been more confident that Mich is poised to dominate in this new world — Dave Portnoy (@stoolpresidente) November 22, 2024 The 6-foot-4 Underwood is now the highest-rated recruit Michigan has ever landed. Underwood’s high school teammate Elijah Dotson flipped his commitment from Pitt to Michigan earlier this week, which seemed to be a sign of what was to come with Underwood. This article first appeared on Larry Brown Sports and was syndicated with permission.

Chesapeake Wealth Management Buys 104 Shares of JPMorgan Chase & Co. (NYSE:JPM)

Columbia, a perennial football loser, wins Ivy League title for first time since 1961CoreCivic executive Cole Carter sells $174,400 in stock

--(BUSINESS WIRE)--Dec 3, 2024-- UnitedHealth Group (NYSE: UNH) issued financial guidance ahead of its annual Investor Conference which takes place on December 4, beginning at 8:00 a.m. ET. UnitedHealth Group will introduce its 2025 outlook which includes revenues of $450 billion to $455 billion, net earnings of $28.15 to $28.65 per share and adjusted net earnings of $29.50 to $30.00 per share. Adjusted net earnings only excludes the after-tax non-cash amortization expense pertaining to acquisition-related intangible assets. Cash flows from operations are expected to range from $32 billion to $33 billion. As announced in the third quarter earnings release, UnitedHealth Group 2024 net earnings are expected to be $15.50 to $15.75 per share and adjusted net earnings $27.50 to $27.75 per share. The company will stream the Investor Conference presentation and management question-and-answer portion of this meeting on its Investor Relations page at www.unitedhealthgroup.com . Meeting materials and a replay of the conference will be available on the Investor Relations page. About UnitedHealth Group UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn . Non-GAAP Financial Information This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release. Forward-Looking Statements The statements, estimates, projections, guidance or outlook contained in this document include “forward-looking” statements which are intended to take advantage of the “safe harbor” provisions of the federal securities laws. The words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,” “outlook,” “plan,” “project,” “should” and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; the DOJ’s legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; risks and uncertainties associated with our businesses providing pharmacy care services; competitive pressures, including our ability to maintain or increase our market share; changes in or challenges to our public sector contract awards; failure to achieve targeted operating cost productivity improvements; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers; the impact of potential changes in tax laws and regulations; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to complete, manage or integrate strategic transactions; risk and uncertainties associated with the continuing sale of operations in South America; risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events; failure to attract, develop, retain, and manage the succession of key employees and executives; our investment portfolio performance; impairment of our goodwill and intangible assets; failure to protect proprietary rights to our databases, software and related products; downgrades in our credit ratings; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, reinvest in our business, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations, more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in the Investor Conference materials, related presentations or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law. UNITEDHEALTH GROUP RECONCILIATION OF NON-GAAP FINANCIAL MEASURE ADJUSTED EARNINGS PER SHARE Use of Non-GAAP Financial Measure Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. Management believes the use of adjusted net earnings per share provides investors and management useful information about the earnings impact of the following items: Intangible Amortization: As amortization fluctuates based on the size and timing of the Company’s acquisition activity, management believes this exclusion presents a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company’s revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share. South American Impacts: Represents the effects of various international transactions, including the loss on sale of our Brazilian operations that was completed on February 6, 2024, the loss on our remaining South American operations being classified as held for sale and certain other non-recurring matters impacting our South American operations. As these matters are related to the Company's strategy to exit South America, the impact is not representative of the Company's underlying business performance and therefore management believes the exclusion presents a more useful comparison of the Company's underlying business performance and trends from period to period. Direct Response Costs - Cyberattack: Management believes the exclusion of costs incurred to investigate and remediate the attack, other direct and incremental costs incurred as a result of the cyberattack and incremental costs for accommodations to support care providers presents a more useful comparison of the Company's and its reportable segments' underlying business performance and trends from period to period. Projected Year Ended December 31, 2024 2025 Net earnings attributable to UnitedHealth Group common shareholders $14,375 - $14,650 $25,850 - $26,450 Intangible amortization ~1,665 ~1,625 Tax effect of intangible amortization ~(410) ~(400) South American impacts ~8,515 — Tax effect of South American impacts ~(175) — Direct response costs - cyberattack ~2,000 — Tax effect of direct response costs - cyberattack ~(470) — Adjusted net earnings attributable to UnitedHealth Group common shareholders $25,500 - $25,775 $27,075 - $27,675 Diluted earnings per share $15.50 - $15.75 $28.15 - $28.65 Intangible amortization per share ~1.80 ~1.75 Tax effect of intangible amortization per share ~(0.45) ~(0.40) South American impacts per share ~9.15 — Tax effect of South American impacts per share ~(0.15) — Direct response costs - cyberattack per share ~2.15 — Tax effects of direct response costs - cyberattack per share ~(0.50) — Adjusted diluted earnings per share $27.50 - $27.75 $29.50 - $30.00 View source version on businesswire.com : https://www.businesswire.com/news/home/20241203502829/en/ CONTACT: Investors: Zack Sopcak Zack.Sopcak@uhg.com 952-936-7215Media: Eric Hausman Eric.Hausman@uhg.com 952-936-3963 KEYWORD: MINNESOTA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: PROFESSIONAL SERVICES HEALTH INSURANCE PRACTICE MANAGEMENT HEALTH INSURANCE MANAGED CARE SOURCE: UnitedHealth Group Copyright Business Wire 2024. PUB: 12/03/2024 04:15 PM/DISC: 12/03/2024 04:13 PM http://www.businesswire.com/news/home/20241203502829/enFormer US President Donald Trump has once again vowed to release the remaining classified records related to President John F. Kennedy’s assassination, reigniting public interest in one of America’s most enduring mysteries. Assembly Election Results Live Updates Maharashtra Election Results Jharkhand Election Results Bypoll Election Results During his ongoing 2024 presidential campaign, Trump has reiterated this commitment, a promise he first made during his presidency but failed to fulfill. At a recent rally in Arizona, Trump announced plans to establish a commission to investigate assassination attempts, with a focus on unveiling all remaining JFK assassination files , as mentioned in a report by Forbes. Also Read: Will Trump fire DoJ lawyers who investigated him during Biden's tenure? Here's what his plans are This declaration came after Robert F. Kennedy Jr., nephew of JFK, endorsed Trump following the withdrawal of his independent presidential bid. Trump described this move as a tribute to Kennedy Jr., who has long advocated for transparency in the case. Office Productivity Mastering Microsoft Office: Word, Excel, PowerPoint, and 365 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Excel Essentials to Expert: Your Complete Guide By - Study At Home, Quality Education Anytime, Anywhere View Program Office Productivity Microsoft Word Mastery: From Beginner to Expert By - CA Raj K Agrawal, Chartered Accountant View Program Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Tabnine AI Masterclass: Optimize Your Coding Efficiency By - Metla Sudha Sekhar, IT Specialist and Developer View Program Leadership Business Storytelling Masterclass By - Ameen Haque, Founder of Storywallahs View Program Finance Financial Literacy for Non-Finance Executives By - CA Raja, Chartered Accountant | Financial Management Educator | Former AVP - Credit, SBI View Program Marketing Marketing & Sales Strategies for Startups: From Concept to Conversion By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Leadership From Idea to Product: A Startup Development Guide By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Web Development JavaScript Essentials: Unlock AI-Driven Insights with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Advanced C++ Mastery: OOPs and Template Techniques By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Generative AI for Dynamic Java Web Applications with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Advanced Java Mastery: Object-Oriented Programming Techniques By - Metla Sudha Sekhar, IT Specialist and Developer View Program Leadership Validating Your Startup Idea: Steps to Ensure Market Fit By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Marketing Digital Marketing Masterclass by Pam Moore By - Pam Moore, Digital Transformation and Social Media Expert View Program Marketing Digital marketing - Wordpress Website Development By - Shraddha Somani, Digital Marketing Trainer, Consultant, Strategiest and Subject Matter expert View Program Marketing Performance Marketing for eCommerce Brands By - Zafer Mukeri, Founder- Inara Marketers View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Finance A2Z Of Money By - elearnmarkets, Financial Education by StockEdge View Program Finance Startup Fundraising: Essential Tactics for Securing Capital By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Strategy Succession Planning Masterclass By - Nigel Penny, Global Strategy Advisor: NSP Strategy Facilitation Ltd. View Program Data Science SQL for Data Science along with Data Analytics and Data Visualization By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance Financial Literacy i.e Lets Crack the Billionaire Code By - CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator View Program Marketing Future of Marketing & Branding Masterclass By - Dr. David Aaker, Professor Emeritus at the Haas School of Business, UC Berkeley, Author | Speaker | Thought Leader | Branding Consultant View Program The Mystery of Unreleased Files While the National Archives holds over five million documents related to the JFK assassination, approximately 3,000 records remain classified or heavily redacted. These files contain sensitive information such as names and addresses, reportedly withheld due to national security concerns. The 1992 President John F. Kennedy Assassination Records Collection Act mandated the release of all assassination-related records by 2017, barring those posing security risks. However, both Trump and President Joe Biden delayed the full release, citing concerns over potential threats to informants and government personnel. In 2022, reports indicated that bureaucratic disputes have contributed to the continued redactions. Despite these delays, Trump authorized the release of about 50,000 documents during his presidency, while Biden declassified 15,000 more files. Still, the public eagerly awaits full disclosure. Also Read: After losing U.S election, Vice President Kamala Harris goes on vacation; here's where she has gone Trump’s Perspective on the Files In various interviews, Trump has hinted at the sensitivity of the remaining documents. Speaking on the “All In” podcast in June, he suggested that the CIA may have influenced his decision to delay the release. He described receiving warnings from trusted advisors, including former Secretary of State Mike Pompeo, who expressed concerns over the potential fallout. “I think it’s going to be fine to open the rest,” Trump said, adding that the files may not contain groundbreaking revelations. Despite his optimism, critics remain skeptical about whether he will follow through if re-elected. What the Files Have Revealed So Far Experts agree that previously declassified records have not significantly altered the official narrative of JFK’s assassination. However, some documents have provided intriguing details, such as evidence of CIA surveillance on Lee Harvey Oswald, Kennedy’s alleged assassin. Jefferson Morley, a historian and editor of the JFK Facts Substack, noted that intelligence agencies appear to have actively suppressed certain details from public view. While these revelations may not rewrite history, they add layers to the understanding of intelligence operations during the Cold War era. A Legacy of Speculation The assassination of John F. Kennedy in Dallas on November 22, 1963, remains a watershed moment in U.S. history. Official investigations, including the Warren Commission, concluded there was no broader conspiracy, but unanswered questions have fueled decades of speculation. FAQs Who was responsible for the assassination of President John F. Kennedy? President John F. Kennedy was assassinated on November 22, 1963, in Dallas, Texas. The official investigation by the Warren Commission concluded that Lee Harvey Oswald acted alone in the assassination. However, conspiracy theories suggesting involvement by others, such as the Mafia, the CIA, or other groups, persist. What happened on the day of the JFK assassination? On November 22, 1963, President Kennedy was in a motorcade through downtown Dallas when he was shot in Dealey Plaza. Kennedy was struck by two bullets, one in the upper back and another in the head. He was pronounced dead shortly after arriving at Parkland Memorial Hospital. Assembly Election Results Live Updates Maharashtra Poll Results Highlights 2024 Jharkhand Poll Results Highlights 2024 (You can now subscribe to our Economic Times WhatsApp channel )

By ZEKE MILLER, Associated Press WASHINGTON (AP) — President-elect Donald Trump’s transition team on Tuesday signed an agreement to allow the Justice Department to conduct background checks on his nominees and appointees after a weeks-long delay. The step lets Trump transition aides and future administration staffers obtain security clearances before Inauguration Day to access classified information about ongoing government programs, an essential step for a smooth transiton of power. It also allows those nominees who are up for Senate confirmation to face the background checks lawmakers want before voting on them. Teams of investigators have been standing by to process clearances for Trump aides and advisers. “This agreement with the Department of Justice will ensure President Trump and his team are ready on Day 1 to begin enacting the America First Agenda that an overwhelming majority of our nation supported on Election Day,” said Susie Wiles, Trump’s designate to be White House chief of staff. Related Articles The announcement comes a week after the Trump transition team signed an agreement with the Biden White House to allow transition staff to coordinate with the existing federal workforce before taking office on Jan. 20. The White House agreement was supposed to have been signed by Oct. 1, according to the Presidential Transition Act, and the Biden White House had issued both public and private appeals for Trump’s team to sign on. Security clearances are required to access classified information, including on ongoing operations and threats to the nation, and the Biden White House and outside experts have emphasized to Trump’s team the importance of having cleared personnel before Inauguration Day so they could be fully briefed and ready to run the government. Republican Senators have also insisted on FBI background checks for Trump’s nominees before they face confirmation votes, as has been standard practice for decades. Lawmakers have been particularly interested in seeing the findings of reviews into Trump’s designated nominee for defense secretary, former Fox News host Pete Hegseth, and for Rep. Tulsi Gabbard to be director of national intelligence. “That’s why it’s so important that we have an FBI background check, a committee review of extensive questions and questionnaires, and a public hearing,” said. Sen. Susan Collins, R-Maine on Monday. John Thune, the incoming Senate Republican leader, said the Trump team “understands there’s going to have to be a thorough vetting of all these nominees.” AP congressional correspondent Lisa Mascaro contributed.

The Dallas Cowboys ruled out right guard Zack Martin and cornerback Trevon Diggs with injuries on Saturday, one day prior to a road game against the Washington Commanders. Martin has been dealing with ankle and shoulder injuries and didn't practice at all this week before initially being listed as doubtful to play on Friday. He also physically struggled during Monday night's loss to the Houston Texans. Martin, who turned 34 on Wednesday, has started all 162 games played in 11 seasons with the Cowboys. He's a nine-time Pro Bowl selection and a seven-time first-team All-Pro. Diggs has been dealing with groin and knee injuries. He was listed as questionable on Friday before being downgraded Saturday. Diggs, 26, has 37 tackles and two interceptions in 10 games this season. The two-time Pro Bowl pick led the NFL with 11 picks in 2021 and has 20 in 57 games. The Cowboys elected not to activate receiver Brandin Cooks (knee) for the game. He returned to practice earlier this week and he was listed as questionable on Friday. Dallas activated offensive tackle Chuma Edoga (toe) and defensive end Marshawn Kneeland (knee) off injured reserve Saturday, placed safety Markquese Bell (shoulder) on IR and released defensive end KJ Henry. Tight end Jake Ferguson (concussion) was previously ruled out. Tight end Princeton Fant was elevated from the practice squad to replace him. Cornerback Kemon Hall also was elevated from the practice squad. --Field Level MediaThe "Finest Cultural Gifts from China" Cultural and Tourism Trade Promotion Activity (Special Session for Musical Journey) Held in Pengzhou, Sichuan Province

In Pictures: Jimmy Carter continued campaigning long after leaving powerNone